论文部分内容阅读
目的 :探讨用双歧三联活菌治疗溃疡性结肠炎的临床效果。方法 :对2012年3月至2014年3月我院收治疗的62例溃疡性结肠炎患者的临床资料进行回顾性分析,将其分为观察组和对照组,每组各31例患者。为对照组患者进行常规治疗,为观察组患者在进行常规治疗的基础上加用双歧三联活菌胶囊进行治疗,并对比观察两组患者在进行治疗前后临床症状改善的情况及临床疗效。结果 :观察组患者治疗的总有效率明显高于对照组患者,差异显著(P<0.05),有统计学意义。两组患者在进行治疗前结肠炎症及临床症状的评分相比较,差异不显著(P>0.05),无统计学意义。在进行治疗后,观察组患者结肠炎症及临床症状的评分明显低于对照组患者,差异显著(P<0.05),有统计学意义。结论 :为溃疡性结肠炎患者使用双歧三联活菌胶囊进行治疗可取得理想的效果,可有效地改善其临床症状,此法值得在临床上推广应用。
Objective: To investigate the clinical efficacy of bifidobacterium triple therapy for ulcerative colitis. Methods: The clinical data of 62 patients with ulcerative colitis treated in our hospital from March 2012 to March 2014 were retrospectively analyzed. They were divided into observation group and control group, with 31 patients in each group. The patients in the control group were treated routinely with bifid triple viable capsule for the treatment of observation group, and the clinical symptoms and clinical outcomes were compared between the two groups before and after treatment. Results: The total effective rate of treatment in observation group was significantly higher than that in control group (P <0.05), with statistical significance. There was no significant difference between the two groups in the scores of colitis and clinical symptoms before treatment (P> 0.05). After treatment, the scores of colon inflammation and clinical symptoms in observation group were significantly lower than those in control group (P <0.05), which were statistically significant. Conclusion: The treatment of patients with ulcerative colitis using bifid triple active bacteria capsules can achieve the desired effect, which can effectively improve their clinical symptoms, this method deserves to be widely used in clinical practice.